The table below enables you to filter the 82 warning letters the FDA issued in 2022 by five categories: country, basis, facility type, dosage form and top problem area. Click on the rows to see the warning letters.
The FDA sent warning letters last year to facilities in 10 countries and one US territory, Puerto Rico. In the past, all were based on inspections, and in 2022, most were based on inspections. But some were based on remote records reviews, FDA testing or refusals. The facility type category shows whether the warning letter targets an ingredient supplier, laboratory, compounding pharmacy, outsourcing facility or drug product firm
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?